Aclaris Therapeutics Inc (ACRS)

22.95 -0.88  -3.69% NASDAQ May 7, 20:00 USD
View Full Chart
Price Chart
View All ACRS News


View All Events


Date Type Description
11/04/2021 17:00 Earnings Calls Q3 2021 Earnings Call
08/06/2021 00:00 Earnings Results Q2 2021 Earnings Results
02/25/2021 00:00 Earnings Results Q4 2020 Earnings Results
11/04/2020 00:00 Earnings Results Q3 2020 Earnings Results
08/07/2020 00:00 Earnings Results Q2 2020 Earnings Results
06/04/2020 09:00 EDT AGM 2019 Annual General Meeting
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are ATI-450, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777.
  • URL:
  • Investor Relations URL:!investors/juser
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: Feb. 25, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PTH Invesco DWA Healthcare Momentum ETF 2.82%
DWMC AdvisorShares Dorsey Wright Micro-Cp ETF 1.62%
DWAS Invesco DWA SmallCap Momentum ETF 1.31%
LGSCX QS US Small Capitalization Equity FI 0.70%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.